Chemotherapy before surgery for high-risk kidney/ureter cancer
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether giving chemotherapy before surgery can help people with high-risk upper tract urothelial cancer (a cancer in the kidney or ureter). The goal is to see if it improves outcomes for those who are healthy enough to receive cisplatin-based chemotherapy and undergo surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a type of cancer called upper tract urothelial carcinoma (UTUC), which is a cancer in the lining of the kidney or ureter.
- Your cancer is high-risk but has not spread to other parts of the body (lymph nodes or distant organs).
- You are planning to undergo surgery to remove the affected kidney, ureter, and part of the bladder.
- You are generally healthy (able to do daily activities without much help) and have good kidney function to tolerate chemotherapy.
- You are at least 18 years old and have recovered from any side effects of previous surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy (gemcitabine) and a targeted drug (Trastuzumab Rezetecan) before surgery to remove the kidney and ureter. It may help shrink the tumor and improve outcomes for people with HER2-positive upper tract urothelial cancer.
This study is testing whether giving a single dose of chemotherapy directly into the kidney and ureter right after a scope procedure helps prevent upper urinary tract tumors from coming back. It’s for people who are about to have a scope to diagnose or treat a suspected or known tumor in the upper urinary tract.
This Phase 3 trial studies giving cisplatin-based chemotherapy before surgery for certain newly diagnosed upper-urinary-tract urothelial cancers (kidney/ureter). It may help shrink the cancer and improve outcomes by treating microscopic disease earlier.
This study tests whether giving chemotherapy before surgery can help patients with high-grade upper tract cancer that hasn't spread. It aims to find better ways to treat this aggressive cancer.
This trial tests whether giving radiation therapy before surgery can help people with high-risk upper tract urothelial cancer (UTUC). The goal is to improve treatment outcomes for patients who are planning to have their cancer removed.
This trial tests whether combining the immunotherapy drug tislelizumab with the chemotherapy drug nab-paclitaxel before surgery can help treat high-risk upper tract urothelial cancer. The goal is to shrink the tumor and improve outcomes for patients who are planning to have their kidney and ureter removed.
Hear when a new UTUC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.